The Synthesis and Biological Evaluation of Pyrrole Containing Marine Natural Prod

Information

  • Research Project
  • 7354888
  • ApplicationId
    7354888
  • Core Project Number
    R15CA067236
  • Full Project Number
    2R15CA067236-04
  • Serial Number
    67236
  • FOA Number
    PA-06-42
  • Sub Project Id
  • Project Start Date
    7/1/1996 - 28 years ago
  • Project End Date
    1/31/2011 - 14 years ago
  • Program Officer Name
    LEES, ROBERT
  • Budget Start Date
    2/1/2008 - 17 years ago
  • Budget End Date
    1/31/2011 - 14 years ago
  • Fiscal Year
    2008
  • Support Year
    4
  • Suffix
  • Award Notice Date
    1/29/2008 - 17 years ago
Organizations

The Synthesis and Biological Evaluation of Pyrrole Containing Marine Natural Prod

[unreadable] DESCRIPTION (provided by applicant): This proposal represents a continuation of work initiated under NIH AREA grant CA 67236 03. Natural products of marine origin continue to be a rich source of biologically interesting compounds and pyrrole containing marine natural products in particular have demonstrated activity as antitumor agents, multidrug resistant reversal agents and inhibitors of HIV integrase. These pyrrole containing natural products are usually characterized by highly oxygenated phenyl groups at carbons 3 and 4 of the pyrrole ring system along with carbonyl containing functionality located at carbons 2 and 5. The synthetic methodology that we have now established allows rapid construction of highly substituted and highly functionalized pyrroles. This methodology also allows for great structural diversity for structure activity relationship (SAR) studies, which could lead to chemotherapeutic agents with increased potency and decreased toxic side effects. Work proposed for the new funding cycle will involve applying this same strategy along with some new and complimentary methodology to the synthesis of marine natural products of the rigidin family (B,C and D), the ningalin family (A and C), permethyl storniamide and lamellarin G trimethyl ether. Proof of concept has recently been established for this new and complementary strategy involving 1) the application of microwave assisted Vilsmeier Haack formylation of highly substituted pyrroles and 2) the generation and base mediated cyclization of ynenoic acid amides. These methodologies, in addition to our general strategy, will allow us to extend our targets to additional important members of this ever growing class of bioactive, pyrrole containing, marine natural products. In addition to exploring these new methodologies, we will continue to evaluate new and novel analogs of our lead compound , which has already been evaluated both in vitro and in vivo against various cancer cell lines and continues to exhibit promising results (average IC50 = 62 nanomolar). All of the target molecules, their precursors and their analogs will subsequently be bioassayed by collaborators and/or the NCI. Mode of action and SAR studies will also be carried out in conjunction with our collaborators. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R15
  • Administering IC
    CA
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    202555
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
    SCHOOLS OF ARTS AND SCIENCES
  • Funding ICs
    NCI:202555\
  • Funding Mechanism
  • Study Section
    SBCB
  • Study Section Name
    Synthetic and Biological Chemistry B Study Section
  • Organization Name
    UNIVERSITY OF RICHMOND
  • Organization Department
    CHEMISTRY
  • Organization DUNS
    056915069
  • Organization City
    RICHMOND
  • Organization State
    VA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    23173
  • Organization District
    UNITED STATES